ArticleMicrosystems & nanoengineering2026
All-optical strategy for high-speed and subcellular precision drug delivery using Airy beams.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Drug delivery strategies with excellent spatiotemporal controllability and biocompatibility hold exciting prospects in personalized medicine and biopharmaceuticals. Among them, all-optical delivery strategies have attracted significant attention due to their low invasiveness and high positioning accuracy. However, current all-optical schemes predominantly rely on conservative optical gradient force trapping or transient scattering forces propulsion, which cannot sustain stable driving and limit delivery speed. Here, we present an all-optical delivery strategy based on Airy beam, enabling high-speed and subcellular-precision delivery through the synergistic regulation of gradient-scattering forces. The dominant scattering force of Airy beams propels drug carriers at speeds exceeding 400 µm/s, while the gradient force ensures a subcellular delivery precision of ~1 µm during high-speed propulsion. Quantitative measurements using a custom axial imaging module reveal at least a 7-fold speed enhancement over conventional all-optical methods. When applied to anticancer drug delivery, the localized mechanical forces generated by high-speed propulsion enhance stable adhesion of carriers to the cell membrane, thereby promoting drug uptake and accelerating tumor cells apoptosis. This work establishes Airy beams as a powerful tool for drug delivery, opening a new avenue for high-performance all-optical delivery platforms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.